HARMONIC INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that HARMONIC INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | $120.22M | Feb 28, 2014 |
| FY2013 | Sep 27, 2013 | $122.92M | Feb 28, 2014 |
| FY2013 | Jun 28, 2013 | $117.13M | Feb 28, 2014 |
| FY2013 | Mar 29, 2013 | $101.67M | Feb 28, 2014 |
| FY2013 | Dec 31, 2012 | $117.98M | Feb 28, 2014 |
| FY2013 | Sep 28, 2012 | $120.39M | Feb 28, 2014 |
| FY2013 | Jun 29, 2012 | $122.06M | Feb 28, 2014 |
| FY2013 | Mar 30, 2012 | $116.44M | Feb 28, 2014 |
| FY2012 | Dec 31, 2011 | $143.63M | Mar 1, 2013 |
| FY2012 | Sep 30, 2011 | $138.87M | Mar 1, 2013 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $360.52M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $488.20M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $388.48M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $624.96M | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $507.15M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $378.83M | Oct 2, 2023 |
| FY2019 | Dec 31, 2019 | $122.18M | Mar 2, 2020 |
| FY2019 | Sep 27, 2019 | $115.73M | Mar 2, 2020 |
| FY2019 | Jun 28, 2019 | $84.87M | Mar 2, 2020 |
| FY2019 | Mar 29, 2019 | $80.11M | Mar 2, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $100.97M | Mar 5, 2018 |
| FY2017 | Sep 29, 2017 | $92.01M | Mar 5, 2018 |
| FY2017 | Jun 30, 2017 | $82.32M | Mar 5, 2018 |
| FY2017 | Mar 31, 2017 | $82.94M | Mar 5, 2018 |
| FY2017 | Dec 31, 2016 | $113.10M | Mar 5, 2018 |
| FY2017 | Sep 30, 2016 | $101.41M | Mar 5, 2018 |
| FY2017 | Jul 1, 2016 | $109.57M | Mar 5, 2018 |
| FY2017 | Apr 1, 2016 | $81.83M | Mar 5, 2018 |
| FY2016 | Dec 31, 2015 | $86.60M | Mar 3, 2017 |
| FY2016 | Oct 2, 2015 | $83.31M | Mar 3, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $174.75M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $240.11M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $178.12M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $315.88M | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $259.74M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $195.00M | Oct 2, 2023 |
| FY2019 | Dec 31, 2019 | $61.70M | Mar 2, 2020 |
| FY2019 | Sep 27, 2019 | $75.54M | Mar 2, 2020 |
| FY2019 | Jun 28, 2019 | $43.93M | Mar 2, 2020 |
| FY2019 | Mar 29, 2019 | $41.85M | Mar 2, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($43.31M) | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $39.22M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $83.99M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $28.18M | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $13.25M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | ($29.27M) | Oct 2, 2023 |
| FY2019 | Dec 31, 2019 | $5.57M | Mar 2, 2020 |
| FY2019 | Sep 27, 2019 | $11.66M | Mar 2, 2020 |
| FY2019 | Jun 28, 2019 | ($11.85M) | Mar 2, 2020 |
| FY2019 | Mar 29, 2019 | ($11.31M) | Mar 2, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.08M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $74.73M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $30.03M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $45.52M | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $18.81M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | ($12.45M) | Oct 2, 2023 |
| FY2021 | Dec 31, 2019 | $13.08M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | ($5.01M) | Mar 2, 2021 |
| FY2019 | Dec 31, 2017 | ($70.88M) | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | ($67.04M) | Mar 1, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $76.33M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $72.57M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $69.71M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $120.31M | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $102.23M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $82.49M | Oct 2, 2023 |
| FY2021 | Dec 31, 2019 | $84.61M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $89.16M | Mar 2, 2021 |
| FY2019 | Dec 31, 2017 | $95.98M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $98.40M | Mar 1, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $81.38M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $79.17M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $78.27M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $146.72M | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $138.09M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $119.61M | Oct 2, 2023 |
| FY2021 | Dec 31, 2019 | $119.04M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $118.95M | Mar 2, 2021 |
| FY2019 | Dec 31, 2017 | $136.27M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $144.38M | Mar 1, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $107.97M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $61.92M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $7.06M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $5.48M | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $41.02M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $39.16M | Oct 2, 2023 |
| FY2021 | Dec 31, 2019 | $31.30M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $12.28M | Mar 2, 2021 |
| FY2019 | Dec 31, 2017 | $3.06M | Mar 2, 2020 |
| FY2016 | Dec 31, 2016 | $438.0K | Mar 3, 2017 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.08M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $9.19M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $8.48M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $9.25M | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $12.98M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $32.21M | Oct 2, 2023 |
| FY2021 | Dec 31, 2019 | $10.33M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $7.04M | Mar 2, 2021 |
| FY2019 | Dec 31, 2017 | $11.40M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $15.11M | Mar 1, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $718.48M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $796.51M | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $768.21M | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $710.02M | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $693.69M | Oct 2, 2023 |
| FY2021 | Dec 31, 2020 | $591.52M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $587.33M | Mar 2, 2021 |
| FY2019 | Dec 31, 2018 | $510.84M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $508.06M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $554.07M | Mar 5, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $335.24M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $331.25M | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $331.33M | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $385.51M | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $396.89M | Oct 2, 2023 |
| FY2021 | Dec 31, 2020 | $333.22M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $332.47M | Mar 2, 2021 |
| FY2019 | Dec 31, 2018 | $282.59M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $289.72M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $283.43M | Mar 5, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $383.25M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $465.26M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $436.87M | Feb 24, 2026 |
| FY2025 | Dec 31, 2022 | $324.51M | Feb 24, 2026 |
| FY2024 | Dec 31, 2021 | $295.91M | Feb 14, 2025 |
| FY2023 | Dec 31, 2020 | $258.30M | Feb 16, 2024 |
| FY2022 | Dec 31, 2019 | $252.45M | Oct 2, 2023 |
| FY2019 | Jan 1, 2019 | $229.65M | Mar 2, 2020 |
| FY2021 | Dec 31, 2018 | $228.25M | Feb 28, 2022 |
| FY2019 | Jan 1, 2018 | $229.77M | Mar 2, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $60.90M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $60.77M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $60.78M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $237.74M | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $240.21M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $243.67M | Oct 2, 2023 |
| FY2021 | Dec 31, 2019 | $239.78M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $240.62M | Mar 2, 2021 |
| FY2019 | Dec 31, 2017 | $242.83M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $237.28M | Mar 1, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.08B) | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | ($1.95B) | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | ($1.96B) | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | ($2.05B) | Feb 16, 2024 |
| FY2023 | Dec 31, 2021 | ($2.09B) | Feb 16, 2024 |
| FY2021 | Dec 31, 2020 | ($2.10B) | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | ($2.07B) | Mar 2, 2021 |
| FY2019 | Dec 31, 2018 | ($2.07B) | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | ($2.06B) | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | ($1.98B) | Mar 5, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $124.11M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $101.46M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $84.27M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $89.59M | Feb 14, 2025 |
| FY2022 | Dec 31, 2021 | $133.43M | Oct 2, 2023 |
| FY2021 | Dec 31, 2020 | $98.65M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $93.06M | Mar 2, 2021 |
| FY2019 | Dec 31, 2018 | $65.99M | Mar 2, 2020 |
| FY2019 | Dec 31, 2017 | $57.02M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $55.64M | Mar 1, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $112.08M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $114.28M | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $0 | Feb 14, 2025 |
| FY2022 | Dec 31, 2022 | $15.92M | Oct 2, 2023 |
| FY2021 | Dec 31, 2021 | $17.98M | Feb 28, 2022 |
| FY2020 | Dec 31, 2020 | $21.84M | Mar 2, 2021 |
| FY2019 | Dec 31, 2019 | $17.15M | Mar 2, 2020 |
| FY2018 | Dec 31, 2018 | $19.70M | Mar 1, 2019 |
| FY2017 | Dec 31, 2017 | $21.85M | Mar 5, 2018 |
| FY2016 | Dec 31, 2016 | $19.33M | Mar 3, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Oct 2, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Mar 2, 2020 |
| FY2019 | Sep 27, 2019 | 0 | Mar 2, 2020 |
| FY2019 | Jun 28, 2019 | 0 | Mar 2, 2020 |
| FY2019 | Mar 29, 2019 | 0 | Mar 2, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Oct 2, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Mar 2, 2020 |
| FY2019 | Sep 27, 2019 | 0 | Mar 2, 2020 |
| FY2019 | Jun 28, 2019 | 0 | Mar 2, 2020 |
| FY2019 | Mar 29, 2019 | 0 | Mar 2, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 111.19M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 116.74M | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | 112.41M | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | 109.87M | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | 102.96M | Oct 2, 2023 |
| FY2021 | Dec 31, 2020 | 98.20M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | 91.88M | Mar 2, 2021 |
| FY2019 | Dec 31, 2018 | 87.06M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | 82.55M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | 78.46M | Mar 5, 2018 |